The global regenerative medicine market was estimated to be over US$ 13 billion in 2019. It is anticipated to grow at a CAGR of 23.2%from 2019 to 2030.
The significant growth of the market can be attributed to increasing prevalence of chronic as well as genetic disorders followed by increasing demand of medicines and therapies that can help cure and prevent these disorders. Moreover, increasing private and government investments for research & development of regenerative medicines are anticipated to boost the regenerative medicine market over the forecast period. To obtain better insights regarding the market scenario, prominent players are increasingly focusing on mergers, acquisitions or collaborations with smaller regenerative medicine companies. For instance, in Jan 2020, Amgen announced a strategic collaboration with BeiGene a biopharmaceutical company focused on developing molecularly targeted and immuno-oncology drugs for the treatment of cancer. This strategic collaboration will enable Amgen to expand its oncology presence in China.
Get PDF Sample Copy of the Report “Regenerative Medicine Market” @
https://www.marketindustryreports.com/pdf/254
Regenerative Medicine Market Prominent Players
Some of the prominent players in the global regenerative medicine market include Novartis AG, Integra LifeSciences Corporation, Vericel Corporation, MiMedx, Stryker, Spark Therapeutics, Inc., Osiris Therapeutics, Inc., Kite Pharma, Organogenesis Inc. and MEDIPOST among others.
Growing Factors:
In recent years, prevalence and incidences of chronic infectious diseases as well as genetic disorders is increasing. For instance, according to American Cancer Society, in 2019, there were around 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States. Such high incidence rates are thus increasing the demand of medicines that can help to prevent or cure such diseases. Such factors are expected to play a pivotal role in fueling the growth of the market during the forecast period.
Moreover, increasing research on embryonic stem cell and gene therapy by various institutes and prominent players is anticipated to further drive the market growth. For instance, a study was carried out by Moa Fransson, Johan Brännström and team in Sweden on ‘Mesenchymal stromal cells that support endothelial cell interactions in an intramuscular islet transplantation model’. Such research studies have been carried out for the development of regenerative medicines globally, in various research institutes, which are anticipated to propel the market growth during the forecast period. Furthermore growing demand of organ transplant along with increasing number of clinical trials and approval of regenerative medicine products are anticipated to drive the regenerative medicine market.
The global regenerative medicine market is segmented by type, application and region.
By Type:
Cell-Based Immunotherapy & Cell Therapy Products
Tissue-Engineering Products and Gene Therapy Products
By Applications:
Musculoskeletal Disorders,
Oncology,
Ocular Disorders,
Wound Care and Diabetes
Get Incredible Discounts on this Premium Report @
https://www.marketindustryreports.com/discount/254
Regioanal Analysis:
North America is anticipated to hold largest market share in 2019. This largest share can be attributed to factors such as increasing prevalence of chronic and genetic diseases along with rising private-public investments for the R&D of regenerative medicine in this region. Moreover, the presence of prominent players, with strong product pipeline is expected to drive the growth of the regenerative medicine market.
The Research Provides Answers To The Following Key Questions:
1.To categorize and examine the worldwide Regenerative Medicine Market status and future figure comprising, manufacture, utilization, income, record and assumption.
2.To introduce the key Regenerative Medicine Market makers to the readers, manufacture, piece of the pie, income, SWOT analysis and improvement models in the years to come.
3.To divide categorization information by region, product type, manufacturers and applications, and end users.
4.To categorize the worldwide and major areas marketing potential and favored position, opportunities and challenges, limitations and threats.
5.To differentiate remarkable patterns, drivers, impacting factors, on the global scale and districts.
6.To purposely investigate each sub-segment regarding standalone development pattern and their contribution to the industry.
7.To categorize major advancements, for instance, understandings, developments, dispatching of new items, and mergers and acquisitions in the industry.
Table of Contents
- INTRODUCTION
- Market Definition
- Market Classification
- Geographic Scope
- Years Considered for the Study: Historical Years – 2017 & 2018; Base Year – 2019; Forecast Years – 2020 to 2030
- Currency Used
- RESEARCH METHODOLOGY
- Research Framework
- Data Collection Technique
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Methodology
- Bottom Up Approach
- Top Down Approach
- Data Validation and Triangulation
- Market Forecast Model
- Limitations/Assumptions of the Study
- ABSTRACT OF THE STUDY
- MARKET DYNAMICS ASSESSMENT
- Overview
- Drivers
- Barriers/Challenges
- Opportunities
Click Here For Full Referral of the Report (With Toc, Tables, Figures) @
https://www.marketindustryreports.com/regenerative-medicine-market/254
About Market Industry Reports:
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
Contact Us:
Phone: + 91 8956767535
Email: sales@marketindustryreports.com
Website: www.marketindustryreports.com
